Both in Pharmaceuticals
ZOETIS vs Royalty Pharma
Over the past year ZTS returned −28.3% and RPRX returned +78.5%; their daily moves had a correlation of 0.16.
ZTS −28.3% RPRX +78.5%Growth of $1, one year, split-adjusted
| Metric | ZTS | RPRX |
|---|---|---|
| Price | $89.20 | $67.56 |
| Market cap | $36.86B | $30.08B |
| Today | +7.48% | +1.75% |
| 1 month | +25.1% | +19.7% |
| 6 months | −19.8% | +33.2% |
| Year to date | −29.1% | +74.8% |
| 1 year | −38.2% | +81.1% |
| Revenue growth (YoY) | −0.2% | +16.5% |
| Gross margin | 72.7% | 100.0% |
| Net margin | 28.0% | 2.7% |
| P/E (TTM) | 14.1× | 36.9× |
| Price / sales | 3.9× | 11.9× |
| Net cash | -$7.37B | -$8.23B |
| Dividend yield | 2.38% | 1.39% |
| Volatility (60d) | 32.1% | 24.8% |
| Short % of float | 4.2% | 2.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).